[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100469058":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":30,"locations":39,"responsibleParty":56,"collaborators":11,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":11,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":11,"enrollmentInfo":67,"targetDuration":11,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":11,"overallStatus":41,"whyStopped":11,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"NYU Langone Health","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Decision Aid (DA) Web Tool","EXPERIMENTAL",null,[13],"Other: Decision Aid (DA) Web Tool",{"label":15,"type":16,"description":11,"interventionNames":17},"Institutional Pamphlet","ACTIVE_COMPARATOR",[18],"Other: Institutional Pamphlet",[20,23],{"type":6,"name":9,"description":21,"armGroupLabels":22,"otherNames":11},"The DA web tool provides information on kidney masses and available treatment options. It uses risk communication, directed teaching, and interactive benefit-harm assessment to present information.",[9],{"type":6,"name":15,"description":24,"armGroupLabels":25,"otherNames":11},"The institutional pamphlet provides information on kidney masses, but does not use risk communication, directed teaching, or interactive benefit-harm assessment.",[15],[27],{"name":28,"affiliation":5,"role":29},"Stella Kang, MD","PRINCIPAL_INVESTIGATOR",[31,35],{"name":28,"role":32,"phone":33,"phoneExt":11,"email":34},"CONTACT","212-263-6246","Stella.kang@nyulangone.org",{"name":36,"role":32,"phone":37,"phoneExt":11,"email":38},"Samantha Sanger","646-501-0086","Samantha.sanger@nyulangone.org",[40],{"facility":5,"status":41,"city":42,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"RECRUITING","New York","10016","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-74.00597,40.71427,{"lat":50,"lon":49},[53,54,55],{"name":28,"role":32,"phone":11,"phoneExt":11,"email":34},{"name":36,"role":32,"phone":11,"phoneExt":11,"email":38},{"name":28,"role":29,"phone":11,"phoneExt":11,"email":11},{"type":57,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100469058","decision-aid-da-for-renal-patients-100469058",false,"NCT05387863","Decision Aid (DA) for Renal Patients","Evaluation of a Decision Aid in the Treatment Planning of Small Renal Tumors","Inclusion Criteria:\n\n* Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.\n* Patients scheduled for standard-of-care clinical exams with the NYU Urology Department\n\nExclusion Criteria:\n\n* Stage IV cancer of any type\n* Inability to provide informed consent\n* Vulnerable subjects will not be recruited","ALL","18 Years",{"count":68,"type":69},40,"ESTIMATED","INTERVENTIONAL",[72],"NA","The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit\u002Fharm estimates to patients and promote patient-centered treatment of renal tumors.",[75,76],"Kidney Tumor","Renal Cancer","2025-11-28",{"date":79,"type":80},"2025-12-02","ACTUAL",{"date":82,"type":80},"2022-09-12",{"date":84,"type":69},"2026-09",{"name":5,"class":6},1]